Higher CD73 expression was seen in lymph nodes of HNSCC patients, and CD73 encouraged HNSCC migration and invasion in vitro by A3R activation via the EGF/EGFR signaling pathway (285). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.